No profile data available.
Yubo International Biotech Limited (YBGJ) is a healthcare company in the additional medication administration equipment industry, based in Beijing, China, with about 14 full-time employees.
It reported revenue of $12,353 for fiscal year 2025, up 256.0% from fiscal year 2024, and net income of -$1.08 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $886,188 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 8, 2026.
Yubo International Biotech Limited, through its subsidiaries, focuses on the research, development, and application of endometrial stem cells.
Yubo International Biotech reported $12,353 in revenue for fiscal year 2025, up 256.0% from $3,470 in fiscal year 2024. In Q2 2026 revenue was $0.
$886,188 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medication administration equipment) include Embecta Corp. (EMBC), Retractable Technologies, Inc. (RVP), Biora Therapeutics, Inc. (BIOR).